George J Mavrothalassitis

Title: George J Mavrothalassitis: Innovator in Genetic Research

Introduction

George J Mavrothalassitis is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of genetic research, particularly through his innovative patents. With a total of 2 patents, Mavrothalassitis has focused on advancements that have the potential to impact cancer treatment.

Latest Patents

Mavrothalassitis's latest patents include the ETS2 repressor factor (ERF). This invention relates to the ERF gene and the products encoded by this gene. More specifically, it involves DNA sequences encoding ERF and AERF, polypeptides encoded by such DNA sequences, ERF chimeric molecules, and methods of using ERF and ERF chimeric molecules to reduce tumorigenicity in tumor cells. Another patent focuses on the ETS2 repressor factor (ERF) genetic locus and its products, reiterating the importance of the ERF gene in cancer research.

Career Highlights

Throughout his career, Mavrothalassitis has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has contributed to the understanding of genetic factors in tumorigenicity.

Collaborations

Mavrothalassitis has collaborated with notable colleagues, including Donald G Blair and Robert J Fisher. These partnerships have furthered his research and innovations in the field of genetics.

Conclusion

George J Mavrothalassitis stands out as an influential inventor in genetic research, with patents that hold promise for advancements in cancer treatment. His contributions continue to shape the landscape of genetic innovation.